Concert Pharma Q1 2022 Earnings Preview

May 04, 2022 1:29 PM ETConcert Pharmaceuticals, Inc. (CNCE)By: Pranav Ghumatkar, SA News Editor
  • Concert Pharma (NASDAQ:CNCE) is scheduled to announce Q1 earnings results on Thursday, May 5th, before market open.
  • The consensus EPS Estimate is -$0.91 (-35.8% Y/Y) and the consensus Revenue Estimate is $0.05M
  • Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.